Skip to main content

Nomogram predicts survival benefit for non-metastatic esophageal cancer patients who underwent preoperative radiotherapy

A prognostic model to predict the individual disease-specific survival (DSS) rates of non-metastatic esophageal cancer (nMEC) patients after preoperative radiotherapy (pRT) has not been established. In the current study, we aimed to establish a survival nomogram for nMEC patients after pRT.
https://www.dovepress.com/nomogram-predicts-survival-benefit-for-non-metastatic-esophageal-cance-peer-reviewed-article-CMAR

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino